This inventor holds 1 USPTO granted patent. Top assignee: Ase & Bio. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Innovations by Vaclav Vetvika
Introduction
Vaclav Vetvika is a notable inventor based in Louisville, KY (US). He has made significant contributions to the field of immunology through his innovative research and patenting efforts. His work focuses on the use of modified oligo-β-(1,3)-glucans for treating various diseases of the immune system.
Latest Patents
Vaclav Vetvika holds a patent for the "Use of modified oligo-β-(1,3)-glucans for treating diseases of the immune system, oligo-β-(1,3)-glucan-(1,3)-mannose, oligo-β-(1,3)-glucan-(1,3)-mannitol and derivatives thereof, methods for preparing them and medicaments containing them." This invention relates to the use of specific compounds for preparing medicaments aimed at treating diseases such as tumors, cancer, viral diseases, bacterial diseases, fungal diseases, and autoimmune diseases in both humans and warm-blooded animals. The patent also covers new products with mannose or mannitol terminations and methods for their preparation.
Career Highlights
Vaclav Vetvika is associated with Ase & Bio, where he continues to advance his research in immunology. His work has led to the development of innovative solutions that address critical health issues related to the immune system.
Collaborations
He collaborates with esteemed colleagues such as Jean-Claude Yvin and Karine Descroix, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Vaclav Vetvika's contributions to the field of immunology through his patent and collaborative efforts highlight his role as a significant inventor. His work continues to pave the way for advancements in treating immune-related diseases.